Antimicrobial and antibiofilm activity of LL-37 and its truncated variants against Burkholderia pseudomallei

Authors
  • H.J.J. de Soet
  • K. Nazmi
  • S. Wongratanacheewin
  • S. Taweechaisupapong
Publication date 2012
Journal International Journal of Antimicrobial Agents
Volume | Issue number 39 | 1
Pages (from-to) 39-44
Organisations
  • Faculty of Dentistry (ACTA)
  • Faculty of Medicine (AMC-UvA)
Abstract
The Gram-negative bacterium Burkholderia pseudomallei is the aetiological agent of melioidosis, which is an endemic disease in tropical areas of Southeast Asia and Northern Australia. Burkholderia pseudomallei has intrinsic resistance to a number of commonly used antibiotics and has also been reported to develop a biofilm. Resistance to killing by antimicrobial agents is one of the hallmarks of bacteria grown in biofilm. The aim of this study was to determine the antimicrobial activity and mechanisms of action of LL-37 and its truncated variants against B. pseudomallei both in planktonic and biofilm form, as LL-37 is an antimicrobial peptide that possessed strong killing activity against several pathogens. Antimicrobial assays revealed that LL-31, a truncated variant of LL-37 lacking the six C-terminus residues, exhibited the strongest killing effect. Time-kill experiments showed that 20 μM LL-31 can reach the bactericidal endpoint within 2 h. Freeze-fracture electron microscopy of bacterial cells demonstrated that these peptides disrupt the membrane and cause leakage of intracellular molecules leading to cell death. Moreover, LL-31 also possessed stronger bactericidal activity than ceftazidime against B. pseudomallei grown in biofilm. Thus, LL-31 should be considered as a potent antimicrobial agent against B. pseudomallei both in planktonic and biofilm form.
Document type Article
Language English
Published at https://doi.org/10.1016/j.ijantimicag.2011.09.010
Permalink to this page
Back